Investigation of the enhanced antimicrobial activity of combination dry powder inhaler formulations of lactoferrin
- 1 December 2016
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 514 (2) , 399-406
Abstract
No abstract availableKeywords
Funding Information
- Aston University
This publication has 24 references indexed in Scilit:
- Metabolite-enabled eradication of bacterial persisters by aminoglycosidesNature, 2011
- Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilmsJournal of Antimicrobial Chemotherapy, 2010
- Chelated iron sources are inhibitors ofPseudomonas aeruginosabiofilms and distribute efficiently in anin vitromodel of drug delivery to the human lungJournal of Applied Microbiology, 2008
- In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic culturesInternational Journal of Antimicrobial Agents, 2008
- Chelator-Induced Dispersal and Killing of Pseudomonas aeruginosa Cells in a BiofilmApplied and Environmental Microbiology, 2006
- Loss of Microbicidal Activity and Increased Formation of Biofilm Due to Decreased Lactoferrin Activity in Patients with Cystic FibrosisThe Journal of Infectious Diseases, 2004
- Matrix metalloproteases in BAL fluid of patients with cystic fibrosis and their modulation by treatment with dornase alphaThorax, 2002
- Comparison of a β-lactam alone versus β-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosisThe Journal of Pediatrics, 1999
- Lactoferrin increases the susceptibility of S. epidermidis biofilms to lysozyme and vancomycinCurrent Eye Research, 1999
- Cell-to-Cell Signaling and Pseudomonas aeruginosa InfectionsEmerging Infectious Diseases, 1998